TY - JOUR
T1 - Toxicities from Antibody-Drug Conjugates
AU - Johns, Andrew C.
AU - Campbell, Matthew T.
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Antibody-drug conjugates are becoming increasingly important in the treatment of many cancer types. The 3 main structural components - antibody, linker, and payload - each contribute to the toxicity profiles of these drugs. In addition to cytopenias and gastrointestinal adverse effects attributed to the chemotherapy payloads, each drug has specific toxicities that are not commonly described in oncology. Ocular, pulmonary, dermatologic, and neurologic toxicities are particularly nuanced. This review provides a framework for clinicians to analyze current and future antibody-drug conjugates and a description of the unique monitoring, preventive, and supportive care measures for these agents.
AB - Antibody-drug conjugates are becoming increasingly important in the treatment of many cancer types. The 3 main structural components - antibody, linker, and payload - each contribute to the toxicity profiles of these drugs. In addition to cytopenias and gastrointestinal adverse effects attributed to the chemotherapy payloads, each drug has specific toxicities that are not commonly described in oncology. Ocular, pulmonary, dermatologic, and neurologic toxicities are particularly nuanced. This review provides a framework for clinicians to analyze current and future antibody-drug conjugates and a description of the unique monitoring, preventive, and supportive care measures for these agents.
KW - Antibody-drug conjugate
KW - management
KW - toxicity
UR - http://www.scopus.com/inward/record.url?scp=85142402452&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142402452&partnerID=8YFLogxK
U2 - 10.1097/PPO.0000000000000626
DO - 10.1097/PPO.0000000000000626
M3 - Review article
C2 - 36383910
AN - SCOPUS:85142402452
SN - 1528-9117
VL - 28
SP - 469
EP - 478
JO - Cancer Journal (United States)
JF - Cancer Journal (United States)
IS - 6
ER -